National Institute of Neurological Disorders and Stroke; Notice of Closed Meetings, 31950-31951 [2016-11903]
Download as PDF
<![CDATA[
31950
Federal Register / Vol. 81, No. 98 / Friday, May 20, 2016 / Notices
Grant recipient/organization name
Grant No.
YALE UNIVERSITY .....................
T20MC21953
Dated: May 13, 2016.
James Macrae,
Acting Administrator.
State
Current project
start date
Current project
end date
7/1/2011
6/30/2016
CT
Dated: May 16, 2016.
Carolyn Baum,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2016–11950 Filed 5–19–16; 8:45 am]
[FR Doc. 2016–11902 Filed 5–19–16; 8:45 am]
BILLING CODE 4165–15–P
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institutes of Health
Eunice Kennedy Shriver National
Institute of Child Health & Human
Development; Notice of Closed
Meeting
National Heart, Lung, and Blood
Institute; Notice of Closed Meeting
mstockstill on DSK3G9T082PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Eunice Kennedy
Shriver National Institute of Child Health
and Human Development Special Emphasis
Panel.
Date: June 23, 2016.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health, 6710 B
Rockledge Drive, Bethesda, MD 20817,
(Telephone Conference Call).
Contact Person: Sathasiva B. Kandasamy,
Ph.D., Scientific Review Officer, Division of
Scientific Review, Eunice Kennedy Shriver
National Institute of Child Health and
Human Development, NIH, 6100 Executive
Boulevard, Room 5B01, Bethesda, MD
20892–9304, (301) 435–6680, skandasa@
mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.864, Population Research;
93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation
Research; 93.209, Contraception and
Infertility Loan Repayment Program, National
Institutes of Health, HHS)
VerDate Sep<11>2014
17:40 May 19, 2016
Jkt 238001
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
Clinical Research for Children—SBIR Topic
86.
Date: June 8, 2016.
Time: 2:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health, 6701
Rockledge Drive, Room 7196, Bethesda, MD
20892 (Telephone Conference Call).
Contact Person: Stephanie J. Webb, Ph.D.,
Scientific Review Officer, Office of Scientific
Review/DERA, National Heart, Lung, and
Blood Institute, 6701 Rockledge Drive, Room
7196, Bethesda, MD 20892, 301–435–0291,
stephanie.webb@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: May 16, 2016.
Carolyn Baum,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2016–11900 Filed 5–19–16; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00042
Fmt 4703
Sfmt 4703
Revised
project end
date
6/30/2017
FY 2015
authorized
funding level
FY 2016
estimated
funding level
15,000
15,000
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel; Blueprint Contract Review.
Date: June 14, 2016.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda Marriott, 5151 Pooks Hill
Road, Bethesda, MD 20814.
Contact Person: Joel A. Saydoff, Ph.D.,
Scientific Review Administrator, Scientific
Review Branch, NINDS/NIH/DHHS,
Neuroscience Center, 6001 Executive Blvd.,
Suite 3204, MSC 9529, Bethesda, MD 20892–
9529, 301–496–9223, joel.saydoff@nih.gov.
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel; R25’s.
Date: June 20, 2016.
Time: 10:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852, (Telephone
Conference Call).
Contact Person: Jo A. McConnell, Scientific
Review Administrator, Scientific Review
Branch, NINDS/NIH/DHHS, Neuroscience
Center, 6001 Executive Blvd., Suite 3204,
MSC 9529, Bethesda, MD 20892–9529,
jo.cmcconnell@nih.gov.
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel; Centers Without Walls for
Collaborative Research in Epilepsies SEP.
Date: June 28–29, 2016.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
E:\FR\FM\20MYN1.SGM
20MYN1
Federal Register / Vol. 81, No. 98 / Friday, May 20, 2016 / Notices
Place: Embassy Suites Alexandria Old
Town, 1900 Diagonal Road, Alexandria, VA
22314.
Contact Person: Elizabeth A. Webber,
Ph.D., Scientific Review Administrator,
Scientific Review Branch, NINDS/NIH/
DHHS, Neuroscience Center, 6001 Executive
Blvd., Suite 3204, MSC 9529, Bethesda, MD
20892–9529, 301–496–1917, webbere@
mail.nih.gov.
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel; NINDS Diversity R25
Review.
Date: June 30, 2016.
Time: 10:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852, (Telephone
Conference Call).
Contact Person: Ernest W. Lyons, Ph.D.,
Scientific Review Administrator, Scientific
Review Branch, NINDS/NIH/DHHS,
Neuroscience Center, 6001 Executive Blvd.,
Suite 3204, MSC 9529, Bethesda, MD 20892–
9529, 301–496–4056, lyonse@ninds.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS)
Dated: May 16, 2016.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2016–11903 Filed 5–19–16; 8:45 am]
BILLING CODE 4140–01–P
National Institutes of Health
mstockstill on DSK3G9T082PROD with NOTICES
National Institute of Allergy and
Infectious Diseases Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Rapid Assessment of Zika
Virus (ZIKV) Complications (R21).
17:40 May 19, 2016
Jkt 238001
Dated: May 16, 2016.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2016–11901 Filed 5–19–16; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOMELAND
SECURITY
U.S. Customs and Border Protection
Notice of Issuance of Final
Determination Concerning Certain
Intermodal Containers
U.S. Customs and Border
Protection, Department of Homeland
Security.
ACTION: Notice of final determination.
AGENCY:
This document provides
notice that U.S. Customs and Border
Protection (‘‘CBP’’) has issued a final
determination concerning the country of
origin of a twenty foot long intermodal
container. Based upon the facts
presented, CBP has concluded that the
country of origin of the intermodal
container is the Republic of Korea for
purposes of U.S. Government
procurement.
DATES: The final determination was
issued on May 13, 2016. A copy of the
final determination is attached. Any
party-at-interest, as defined in 19 CFR
177.22(d), may seek judicial review of
this final determination within June 20,
2016.
FOR FURTHER INFORMATION CONTACT:
Teresa M. Frazier, Valuation and
Special Programs Branch, Regulations
and Rulings, Office of Trade (202) 325–
0139.
SUPPLEMENTARY INFORMATION: Notice is
hereby given that pursuant to subpart B
of Part 177, U.S. Customs and Border
Protection Regulations (19 CFR part 177,
subpart B), CBP issued a final
determination concerning the country of
SUMMARY:
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
VerDate Sep<11>2014
Date: June 14, 2016.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 4H100,
5601 Fishers Lane, Rockville, MD 20892,
(Telephone Conference Call).
Contact Person: Jay R. Radke, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
Room #3G11B, National Institutes of Health,
NIAID, 5601 Fishers Lane MSC–9823,
Bethesda, MD 20892–9823, (240) 669–5046,
jay.radke@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
PO 00000
Frm 00043
Fmt 4703
Sfmt 4703
31951
origin of certain intermodal containers,
which may be offered to the U.S.
Government under an undesignated
government procurement contract. This
final determination, HQ H273529, was
issued under procedures set forth at 19
CFR part 177, subpart B, which
implements Title III of the Trade
Agreements Act of 1979, as amended
(19 U.S.C. 2511–18). In the final
determination, CBP concluded that the
processing in Korea results in a
substantial transformation. Therefore,
the country of origin of the intermodal
container is Korea for purposes of U.S.
Government procurement.
Section 177.29, CBP Regulations (19
CFR 177.29), provides that a notice of
final determination shall be published
in the Federal Register within 60 days
of the date the final determination is
issued. Section 177.30, CBP Regulations
(19 CFR 177.30), provides that any
party-at-interest, as defined in 19 CFR
177.22(d), may seek judicial review of a
final determination within 30 days of
publication of such determination in the
Federal Register.
Dated: May 13, 2016.
Myles B. Harmon,
Acting Executive Director, Regulations and
Rulings, Office of Trade.
H273529
May 13, 2016
OT:RR:CTF:VS H273529 TMF
CATEGORY: Country of Origin
Michael G. McManus, Duane Morris LLP, 505
9th Street NW., Suite 1000, Washington,
DC 20004–2166
Re: U.S. Government Procurement; Title III,
Trade Agreements Act of 1979 (19 U.S.C.
2511); Substantial Transformation;
Twenty Foot Intermodal Shipping
Containers
Dear Mr. McManus: This is in response to
your correspondence of February 12, 2016,
requesting a final determination on behalf of
your client, Sea Box, Inc. (‘‘Sea Box’’),
pursuant to subpart B of part 177, U.S.
Customs and Border Protection (CBP)
Regulations (19 CFR 177.21 et seq.). Under
pertinent regulations, which implement Title
III of the Trade Agreements Act of 1979, as
amended (19 U.S.C. 2511 et seq.), CBP issues
country of origin advisory rulings and final
determinations as to whether an article is, or
would be, a product of a designated country
or instrumentality for the purpose of granting
waivers of certain ‘‘Buy American’’
restrictions in U.S. law or practice for
products offered for sale to the U.S.
Government.
This final determination concerns a twenty
foot long Sea Box shipping container that is
claimed to be a product of the Republic of
South Korea or the United States. We note
that Sea Box, Inc. is a party-at-interest within
the meaning of 19 CFR 177.22(d)(1) and is
entitled to request this determination.
E:\FR\FM\20MYN1.SGM
20MYN1
]]>Agencies
[Federal Register Volume 81, Number 98 (Friday, May 20, 2016)]
[Notices]
[Pages 31950-31951]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-11903]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Neurological Disorders and Stroke; Notice
of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Neurological Disorders
and Stroke Special Emphasis Panel; Blueprint Contract Review.
Date: June 14, 2016.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Bethesda Marriott, 5151 Pooks Hill Road, Bethesda, MD
20814.
Contact Person: Joel A. Saydoff, Ph.D., Scientific Review
Administrator, Scientific Review Branch, NINDS/NIH/DHHS,
Neuroscience Center, 6001 Executive Blvd., Suite 3204, MSC 9529,
Bethesda, MD 20892-9529, 301-496-9223, joel.saydoff@nih.gov.
Name of Committee: National Institute of Neurological Disorders
and Stroke Special Emphasis Panel; R25's.
Date: June 20, 2016.
Time: 10:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Neuroscience Center, 6001
Executive Boulevard, Rockville, MD 20852, (Telephone Conference
Call).
Contact Person: Jo A. McConnell, Scientific Review
Administrator, Scientific Review Branch, NINDS/NIH/DHHS,
Neuroscience Center, 6001 Executive Blvd., Suite 3204, MSC 9529,
Bethesda, MD 20892-9529, jo.cmcconnell@nih.gov.
Name of Committee: National Institute of Neurological Disorders
and Stroke Special Emphasis Panel; Centers Without Walls for
Collaborative Research in Epilepsies SEP.
Date: June 28-29, 2016.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
[[Page 31951]]
Place: Embassy Suites Alexandria Old Town, 1900 Diagonal Road,
Alexandria, VA 22314.
Contact Person: Elizabeth A. Webber, Ph.D., Scientific Review
Administrator, Scientific Review Branch, NINDS/NIH/DHHS,
Neuroscience Center, 6001 Executive Blvd., Suite 3204, MSC 9529,
Bethesda, MD 20892-9529, 301-496-1917, webbere@mail.nih.gov.
Name of Committee: National Institute of Neurological Disorders
and Stroke Special Emphasis Panel; NINDS Diversity R25 Review.
Date: June 30, 2016.
Time: 10:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Neuroscience Center, 6001
Executive Boulevard, Rockville, MD 20852, (Telephone Conference
Call).
Contact Person: Ernest W. Lyons, Ph.D., Scientific Review
Administrator, Scientific Review Branch, NINDS/NIH/DHHS,
Neuroscience Center, 6001 Executive Blvd., Suite 3204, MSC 9529,
Bethesda, MD 20892-9529, 301-496-4056, lyonse@ninds.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.853,
Clinical Research Related to Neurological Disorders; 93.854,
Biological Basis Research in the Neurosciences, National Institutes
of Health, HHS)
Dated: May 16, 2016.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-11903 Filed 5-19-16; 8:45 am]
BILLING CODE 4140-01-P
